Huang James
CIK 0001573160
Chief Executive OfficerDirector10% Owner
Filings
15
Latest Jun 2, 2026
Issuers covered
6
Showing
15 of 15
Page 1
Track record
4 of 6 open-market trades scored (67% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 50% | +7.9% | +7.7% | +21.9% | -5.7% |
| 90 days | 3 | 100% | +27.7% | +16.8% | +57.4% | +9.0% |
| 180 days | 2 | 0% | -58.8% | -58.8% | -55.0% | -62.7% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Huang James has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | 6 | May 11, 2026 |
| TCRT | Alaunos Therapeutics, Inc. | 3 | Jun 8, 2023 |
| CNTB | Connect Biopharma Holdings Ltd | 2 | Jun 2, 2026 |
| WINT | Windtree Therapeutics Inc /De/ | 2 | Feb 23, 2023 |
| CASI | Casi Pharmaceuticals, Inc. | 1 | May 26, 2022 |
| ORIA | Orion Biotech Opportunities Corp. | 1 | May 18, 2023 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|